莱伯泰科(688056) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥105,478,954.63, representing a year-on-year increase of 9.19%[4] - The net profit attributable to shareholders decreased by 10.05% to ¥11,574,778.68 compared to the same period last year[4] - The basic earnings per share (EPS) was ¥0.17, reflecting a decrease of 10.53% compared to the previous year[4] - Net profit for Q1 2024 was ¥11,574,778.68, a decrease of 10.0% from ¥12,867,741.35 in Q1 2023[22] - The company reported a basic earnings per share of ¥0.17 for Q1 2024, down from ¥0.19 in Q1 2023[23] Research and Development - Research and development expenses totaled ¥12,347,788.06, accounting for 11.71% of operating revenue, an increase of 1.36 percentage points year-on-year[4] - Research and development expenses increased to ¥12,347,788.06 in Q1 2024, compared to ¥10,000,621.08 in Q1 2023, marking a growth of 23.5%[22] Cash Flow - The net cash flow from operating activities was negative at -¥1,282,305.88, indicating a cash outflow during the quarter[4] - Cash flow from operating activities showed a net outflow of ¥1,282,305.88 in Q1 2024, an improvement from a net outflow of ¥9,963,786.03 in Q1 2023[25] - The net cash flow from investing activities was -$140,634,112.25, a significant decrease compared to $26,657,534.86 in the previous period[26] - The total cash and cash equivalents at the end of the period amounted to $312,429,134.15, down from $386,275,431.70 in the prior year[26] - The net increase in cash and cash equivalents was -$152,306,760.90, contrasting with an increase of $15,446,954.30 in the previous period[26] - Cash outflows from financing activities totaled $10,190,048.43, compared to $156,559.38 in the prior year[26] - The impact of exchange rate changes on cash and cash equivalents was -$200,294.34, compared to -$1,090,235.15 in the previous period[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥989,709,737.18, a decrease of 1.47% from the end of the previous year[5] - As of March 31, 2024, the total assets of the company amounted to ¥989,709,737.18, a decrease from ¥1,004,497,965.18 as of December 31, 2023, reflecting a decline of approximately 1.8%[18] - The company's cash and cash equivalents decreased to ¥321,141,246.28 from ¥472,914,097.10, representing a decline of about 32.1%[15] - The total current assets were reported at ¥783,510,899.11, down from ¥797,748,505.14, indicating a decrease of approximately 1.8%[17] - Total liabilities decreased to ¥137,230,964.54 in Q1 2024 from ¥155,174,803.34 in Q1 2023, a reduction of 11.6%[19] - The total current liabilities decreased to ¥128,227,004.47 from ¥148,366,244.34, reflecting a decline of about 13.6%[18] - The company's non-current assets totaled ¥206,198,838.07, a slight decrease from ¥206,749,460.04, indicating a decline of approximately 0.3%[18] - The company reported a significant reduction in contract liabilities from ¥74,466,404.19 to ¥60,689,040.75, a decrease of approximately 18.5%[18] - The deferred income tax assets increased to ¥5,906,816.59 from ¥4,956,879.45, reflecting an increase of about 19.2%[18] Government Subsidies and Gains - The company received government subsidies amounting to ¥70,208.88, which are closely related to its normal business operations[6] - The total non-recurring gains and losses amounted to ¥1,158,418.08 after tax adjustments[7] Operating Costs - Total operating costs for Q1 2024 were ¥95,653,559.54, up from ¥85,415,435.68 in Q1 2023, reflecting a rise of 12.5%[21]